Polypill Shows LDL Lowering Advantage in High risk Primary Prevention Patients
Cardiovascular polypills are important as a fixed-dose combination of medications with proven benefits for the prevention of cardiovascular disease by combining different drug classes in a single pill to simultaneously target more than one risk factor. Whether the treatment with the CNIC-polypill was at least non-inferior to usual care in terms of low-density lipoprotein cholesterol (LDL-c)...
Cardiovascular polypills are important as a fixed-dose combination of medications with proven benefits for the prevention of cardiovascular disease by combining different drug classes in a single pill to simultaneously target more than one risk factor.
Whether the treatment with the CNIC-polypill was at least non-inferior to usual care in terms of low-density lipoprotein cholesterol (LDL-c) and systolic BP (SBP) values in subjects at high or very high risk without a previous cardiovascular event. The switch from conventional treatment to the CNIC-polypill approach in patients at high Cardiovascular risk without a previous event was safe and appears a reasonable strategy to control risk factors and prevent cardiovascular diseases.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd